These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38457656)

  • 41. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
    Mercurio I; Tragni V; Busto F; De Grassi A; Pierri CL
    Cell Mol Life Sci; 2021 Feb; 78(4):1501-1522. PubMed ID: 32623480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 2D MOF-Based Photoelectrochemical Aptasensor for SARS-CoV-2 Spike Glycoprotein Detection.
    Jiang ZW; Zhao TT; Li CM; Li YF; Huang CZ
    ACS Appl Mater Interfaces; 2021 Oct; 13(42):49754-49761. PubMed ID: 34657424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2.
    Benton DJ; Wrobel AG; Roustan C; Borg A; Xu P; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33579792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generation and utility of a single-chain fragment variable monoclonal antibody platform against a baculovirus expressed recombinant receptor binding domain of SARS-CoV-2 spike protein.
    Salem R; El-Kholy AA; Waly FR; Ayman D; Sakr A; Hussein M
    Mol Immunol; 2022 Jan; 141():287-296. PubMed ID: 34915268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distant residues modulate conformational opening in SARS-CoV-2 spike protein.
    Ray D; Le L; Andricioaei I
    Proc Natl Acad Sci U S A; 2021 Oct; 118(43):. PubMed ID: 34615730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    Choudhury A; Mukherjee S
    J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
    Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
    Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.
    Liu Z; Xiao X; Wei X; Li J; Yang J; Tan H; Zhu J; Zhang Q; Wu J; Liu L
    J Med Virol; 2020 Jun; 92(6):595-601. PubMed ID: 32100877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection.
    Konrath KM; Liaw K; Wu Y; Zhu X; Walker SN; Xu Z; Schultheis K; Chokkalingam N; Chawla H; Du J; Tursi NJ; Moore A; Adolf-Bryfogle J; Purwar M; Reuschel EL; Frase D; Sullivan M; Fry B; Maricic I; Andrade VM; Iffland C; Crispin M; Broderick KE; Humeau LMPF; Patel A; Smith TRF; Pallesen J; Weiner DB; Kulp DW
    Cell Rep; 2022 Feb; 38(5):110318. PubMed ID: 35090597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection.
    Tai W; Zheng J; Zhang X; Shi J; Wang G; Guan X; Zhu J; Perlman S; Du L
    Virus Res; 2023 Sep; 334():199156. PubMed ID: 37336390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Development of Aptamer-Based Gold Nanoparticle Lateral Flow Test Strips for the Detection of SARS-CoV-2 S Proteins on the Surface of Cold-Chain Food Packaging.
    Li X; Wang J; Yang G; Fang X; Zhao L; Luo Z; Dong Y
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2.
    Halder S; Thakur A; Keshry SS; Jana P; Karothia D; Das Jana I; Acevedo O; Swain RK; Mondal A; Chattopadhyay S; Jayaprakash V; Dev A
    Sci Rep; 2023 Sep; 13(1):14560. PubMed ID: 37666993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
    Lata S; Akif M
    J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic Variants.
    Simões RSQ; Rodríguez-Lázaro D
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cryo-EM structure of the SARS-CoV-2 Omicron spike.
    Cerutti G; Guo Y; Liu L; Liu L; Zhang Z; Luo Y; Huang Y; Wang HH; Ho DD; Sheng Z; Shapiro L
    Cell Rep; 2022 Mar; 38(9):110428. PubMed ID: 35172173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dynamics prediction of emerging notable spike protein mutations in SARS-CoV-2 implies a need for updated vaccines.
    Al-Zyoud W; Haddad H
    Biochimie; 2021 Dec; 191():91-103. PubMed ID: 34508827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proof-of-concept for speedy development of rapid and simple at-home method for potential diagnosis of early COVID-19 mutant infections using nanogold and aptamer.
    Ellipilli S; Wang H; Lee WJ; Shu D; Guo P
    Nanomedicine; 2022 Sep; 45():102590. PubMed ID: 35905841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SCORe: SARS-CoV-2 Omicron Variant RBD-Binding DNA Aptamer for Multiplexed Rapid Detection and Pseudovirus Neutralization.
    Yang LF; Kacherovsky N; Liang J; Salipante SJ; Pun SH
    Anal Chem; 2022 Sep; 94(37):12683-12690. PubMed ID: 35972202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Multi-Faceted Binding Assessment of Aptamers Targeting the SARS-CoV-2 Spike Protein.
    Civit L; Moradzadeh N; Jonczyk A; Neckermann P; Asbach B; Peterhoff D; Wagner R; Famulok M; Mayer G; Kjems J; Valero J
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.